These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 2879850

  • 41. Mesoprefrontal cortical dopaminergic activity and prefrontal hypofunction in schizophrenia.
    Weinberger DR, Berman KF, Daniel DG.
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():568A-569A. PubMed ID: 1498953
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Dopaminergic insufficiency reflecting cerebral ageing: value of a dopaminergic agonist, piribedil.
    Ollat H.
    J Neurol; 1992; 239 Suppl 1():S13-6. PubMed ID: 1634905
    [Abstract] [Full Text] [Related]

  • 45. Hypofrontality in schizophrenia.
    Jones BD.
    Can J Psychiatry; 1988 Apr; 33(3):243-5. PubMed ID: 2898284
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Neural plasticity in schizophrenia.
    Haracz JL.
    Schizophr Bull; 1985 Apr; 11(2):191-229. PubMed ID: 4012226
    [Abstract] [Full Text] [Related]

  • 48. Regional cerebral blood flow in schizophrenia: a preliminary report.
    Mathew RJ, Meyer JS, Francis DJ, Schoolar JC, Weinman M, Mortel KF.
    Am J Psychiatry; 1981 Jan; 138(1):112-3. PubMed ID: 7446762
    [No Abstract] [Full Text] [Related]

  • 49. Frontal-lobe hypofunction in schizophrenia.
    Lancet; 1984 Apr 28; 1(8383):969-71. PubMed ID: 6143911
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Evaluation of a structural polymorphism in the ankyrin repeat and kinase domain containing 1 (ANKK1) gene and the activation of executive attention networks.
    Fossella J, Green AE, Fan J.
    Cogn Affect Behav Neurosci; 2006 Mar 28; 6(1):71-8. PubMed ID: 16869231
    [Abstract] [Full Text] [Related]

  • 54. Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex.
    Clinton SM, Sucharski IL, Finlay JM.
    Psychopharmacology (Berl); 2006 Jan 28; 183(4):404-12. PubMed ID: 16307295
    [Abstract] [Full Text] [Related]

  • 55. Assessing the molecular genetics of attention networks.
    Fossella J, Sommer T, Fan J, Wu Y, Swanson JM, Pfaff DW, Posner MI.
    BMC Neurosci; 2002 Oct 04; 3():14. PubMed ID: 12366871
    [Abstract] [Full Text] [Related]

  • 56. Functional brain mapping of psychopathology.
    Honey GD, Fletcher PC, Bullmore ET.
    J Neurol Neurosurg Psychiatry; 2002 Apr 04; 72(4):432-9. PubMed ID: 11909899
    [Abstract] [Full Text] [Related]

  • 57. Functional neuroimaging in psychiatry.
    Fu CH, McGuire PK.
    Philos Trans R Soc Lond B Biol Sci; 1999 Jul 29; 354(1387):1359-70. PubMed ID: 10466156
    [Abstract] [Full Text] [Related]

  • 58. Reversibility of hemodynamic hypofrontality in schizophrenia.
    Geraud G, Arné-Bès MC, Güell A, Bes A.
    J Cereb Blood Flow Metab; 1987 Feb 29; 7(1):9-12. PubMed ID: 2879850
    [Abstract] [Full Text] [Related]

  • 59. Effects of age, neuropsychological impairment, and medication on regional cerebral blood flow in schizophrenia and major affective disorder.
    Goldstein PC, Brown GG, Marcus A, Ewing JR.
    Henry Ford Hosp Med J; 1990 Feb 29; 38(4):202-6. PubMed ID: 1982284
    [Abstract] [Full Text] [Related]

  • 60. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A.
    Dan Med Bull; 2000 Jun 29; 47(3):151-67. PubMed ID: 10913983
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.